Sertraline Pharmacotherapy for Alcoholism Subtypes
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Sertraline, compared to placebo, is
effective in the treatment of alcohol dependence as a function of the subtype of alcoholic
patient being treated. This involved administering sertraline (to a maximum of 200 mg/day) or
an inactive placebo for a 14-week treatment period.
Phase:
Phase 4
Details
Lead Sponsor:
UConn Health
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)